The global gene synthesis market is expected to grow at a sturdy rate of 19.2% during the forecast period. In 2023, the market valuation is expected to be at US$ 779.4 million. By 2033, the estimation is projected to cross US$ 4.5 billion.
Key factors supporting the market growth are:
The ability to synthesize whole genes, metabolic pathways and even genomes has become possible in the last 30 years. Genetic engineering has evolved into a gene synthesis process that creates double-stranded DNA from oligonucleotides using different assembly methods into plasmids for transfection. The evolution has certainly assisted healthcare experts in predicting the pathogen behaviour before it becomes a serious cause of concern.
Various methods are currently used based on DNA complexity and length. The researchers are also in the process of developing a system which processes several samples automatically. To maintain the brand value, the manufacturers are laying a lot of emphasis on Intellectual Property Rights.
EVONETIX LTD has announced that a European patent has been granted for its proprietary Binary Assembly method in gene synthesis. As a result of the patent (EP 3688189 B1), Evonetix has further enhanced its IP portfolio and enabled a new generation of in-lab DNA synthesis platforms. The platform would simplify gene synthesis for researchers. Using the patented method, long DNA molecules can be assembled on-chip, and synthesis errors can be eliminated.
Synthetic genes can be produced at the molecular biology bench using common reagents and procedures, despite their easy availability. Researchers are working hard to develop long DNA molecules in the future. This is believed to assist in producing DNA sequences and proper protein production.
The surging geriatric population is expected to increase the demand for gene synthesis machines. It is crucial in treating many diseases during ageing and helps diagnose. The market has been surging with therapeutic advancements, opening new prospects for gene synthesis. The synthesis of genes and cloning are meant to reduce time and cost. These factors have led government authorities and private enterprises to invest in this technique.
Asia Pacific is expected to grab the lion’s share of the market. New opportunities for biological functionality were found in developing countries throughout the Asia Pacific region, which prompted the introduction of gene synthesis. This region continues to see a rise in geriatrics, as well as an increase in the replication of DNA. The demand for gene synthesis will continue to increase in this region as disposal incomes rise and high-quality healthcare systems expand.
| Attributes | Value |
|---|---|
| Gene Synthesis Market Value (2022) | US$ 643.2 million |
| Gene Synthesis Market Expected Value (2023) | US$ 779.4 million |
| Gene Synthesis Market Forecast Value (2033) | US$ 4.5 billion |
| Gene Synthesis Market Expected CAGR (2023 to 2033) | 19.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The massive expansion of biotechnology and gene research analysis, in particular, has opened new venues for research. With scientists conducting in-depth research on DNA sequences to study the evolution of human beings, the adoption of gene synthesis is expected to surge.
This method is also used in the current research works, which are based on increasing the lifespan of human beings. With so much significance, the market has been displaying robust growth. However, the market might witness a little slump owing to the lockdown and supply chain disruption. While the historical CAGR for the market was 19.9%, the anticipated CAGR is 19.2%.
CRISPR-based therapeutics can be adapted in near-limitless ways using a new gene editing platform developed by Northwestern University researchers.
After the onset of the COVID-19 pandemic, significant companies have invested in vaccine development in response to the ongoing pandemic. As a result, gene synthesis markets using vaccine development-based gene synthesis are expected to show positive growth opportunities soon.
Chemotherapy and immunotherapy combined with targeted therapy will grow considerably in the coming years. This would create lucrative opportunities for both established and emerging companies in the healthcare sector. In addition, the focus on molecular-level research will boost demand for gene synthesis over the next few years as clinical research is intensified. In the near future, synthetic biology may enable the design of microorganisms that are capable of finding cancer cells. Microbes designed for this purpose could secrete toxic proteins that could kill cancer cells with minimal side effects and with precision.
Principal Consultant
Ongoing developments in synthetic DNA technology are gaining popularity as a viable measure to address concerns about the rising pathogens is expected to drive the market growth.
Emergence of novel strains of COVID-19 and growing penetration of targeted therapy are propelling the demand for gene synthesis to assist in characterizing genes. Also, numerous research and development institutes are increasingly adopting gene synthesis techniques to develop highly accurate diagnostics for novel diseases.
For instance, the National Institute of Standards and Technology has announced adopting gene synthesis techniques for producing new synthetic gene fragments from the COVID-19 virus. This would assist the medical testing providers in developing more accurate and reliable diagnostic tests for the disease. A slew of such developments is estimated to favor the growth in the market.
Medical research and academic institutes are supported by strong technological and scientific expertise. They are increasingly focusing on advanced basic research activities, including applied research and synthetic biology, especially when governments prefer cost-effective approaches to conducting development projects.
With a growing demand for advanced recombinant DNA technologies, leading players in the market are extensively aiming at mergers, collaborations, and acquisitions to expand their market. For example, Eurofins Scientific, a leading testing laboratory company, announced the acquisition of a United States-based biotechnology company to expand its gene synthesis capabilities in August 2019. Hence, increasing research and development activities for novel therapeutics and diagnostics development is expected to augment the growth in the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Region | North America |
|---|---|
| Country | United States |
| CAGR (2023 to 2033) | 15.7% |
| Region | Europe |
|---|---|
| Country | United Kingdom |
| CAGR (2023 to 2033) | 21.4% |
| Region | Asia Pacific |
|---|---|
| Country | China |
| CAGR (2023 to 2033) | 29.2% |
| Region | Asia Pacific |
|---|---|
| Country | Japan |
| CAGR (2023 to 2033) | 24.1% |
| Region | Asia Pacific |
|---|---|
| Country | South Korea |
| CAGR (2023 to 2033) | 21.6% |
Rising implementation by drug and diagnostic developers to fuel the gene synthesis demand
As per FMI, the United States is projected to remain a dominant market for gene synthesis in North America between 2023 and 2033.
| Attributes | Details |
|---|---|
| United States Market Expected Size (2033) | US$ 1.3 billion |
| United States Market Absolute Dollar Growth | US$ 965.8 million |
| CAGR % 2017 to 2022 | 17.6% |
Rising implementation of gene editing and synthesis-related procedures by drug and diagnostic developers in the United States is facilitating the demand for gene synthesis. Growing commercialization of synthetic gene products and increasing authorization by regulatory bodies, like the United States Food and Drug Administration, is anticipated to favor growth. Driven by this, North America is anticipated to create an incremental opportunity of more than half a billion by 2033.
Increasing adoption of molecular engineering to bolster gene synthesis sales
FMI states that the United Kingdom is estimated to emerge as a highly remunerative gene synthesis market in Europe over the assessment period.
Numerous research and development startups in the United Kingdom are pursuing the potential of enzymatic synthesis and shifting their preference towards adopting gene synthesis. Gene synthesis offers higher efficiency and rapid method as compared to traditional chemical means.
| Attributes | Details |
|---|---|
| United Kingdom Market Expected Size (2033) | US$ 241.2 million |
| United Kingdom Market Absolute Dollar Growth | US$ 206.4 million |
| CAGR % 2017 to 2022 | 25.8% |
It is extensively being used for synthesizing longer DNA sequences and molecular engineering, which is, in turn, propelling the demand for gene synthesis in the market. In addition, several well-established service laboratories and increasing developments in synthetic biology are expected to facilitate growth in the United Kingdom market.
In China, massive developments are happening in the field of genomics. The researchers are focusing on the development of Next Generation Sequencing, which is expected to significantly impact cellular. Direct Genomics, which is a Chinese firm, makes use of single-molecule targeted sequencing to read DNA and RNA. More such developments are expected to increase the application of gene synthesis.
| Attributes | Details |
|---|---|
| China Market Expected Size (2033) | US$ 905.3 million |
| China Market Absolute Dollar Growth | US$ 835.4 million |
| CAGR % 2017 to 2022 | 28.5% |
China has been witnessing a rapid increase in the adoption of genetic testing. Massive surge in people suffering from chronic diseases has risen the usage of genetic testing. Spur in the availability of direct-to-consumer tests has further propelled the demand for genetic testing. Genetic testing makes use of gene synthesis to identify the nature of the molecule associated with the pathogen.
Increasing focus on novel therapeutics development to augment the sales of gene synthesis service
With growing emphasis on novel therapeutics development, a substantial rise in demand for technologies such as gene synthesis is being observed across various fields. This is particularly observed in recombinant DNA technology, including vaccine development, gene therapy, molecular engineering, and others.
| Attributes | Details |
|---|---|
| Japan Market Expected Size (2033) | US$ 477.6 million |
| Japan Market Absolute Dollar Growth | US$ 422.6 million |
| CAGR % 2017 to 2022 | 25.4% |
Key players are focusing on collaborating with other companies to provide gene synthesis services to expand their market share. For instance, in 2020, Takeda, a Japan-based pharmaceutical company, announced collaborating with a United States-based protein engineering company, Codexis. The partnership focused on providing gene synthesis services to the latter company for developing novel gene therapies for rare genetic disorders. An assortment of such development is estimated to spur sales in the Japan market.
The key players in South Korea are conducting in-depth research on base editing technology. They are using adenine base editors because of their hyper-compact gene editing technology. These are characterized by compactness in size, which can be delivered using an adeno-associated virus. These are known to have specific and versatile base editing activities. The base editing technology is known to make use of gene synthesis to study the structure of DNA and RNA.
| Attributes | Details |
|---|---|
| South Korea Market Expected Size (2033) | US$ 154.8 million |
| South Korea Market Absolute Dollar Growth | US$ 132.9 million |
| CAGR % 2017 to 2022 | 21.2% |
The South Korean government is also making massive investments in the biotechnology market. The government announced an allocation of US$ 303 million to secure key technologies in the area of biotechnology. This represents massive opportunities for the gene synthesis market.
| Segment | Service Type |
|---|---|
| Attributes | Gene Synthesis Service |
| CAGR (2017 to 2022) | 18.3% |
| CAGR (2023 to 2033) | 16.5% |
| Segment | Application |
|---|---|
| Attributes | Research and Development Activities |
| CAGR (2017 to 2022) | 19.6% |
| CAGR (2023 to 2033) | 18.4% |
Increasing standard and custom gene synthesis applications will favor market growth
FMI revealed that the gene synthesis segment is estimated to exhibit rapid growth in the market, accounting for nearly 75% of the gene synthesis sales by the end of 2033.
Within the segment, custom gene synthesis services are estimated to lead the way, owing to increasing applications across immunology, cancer research, antibody discovery, and others. Apart from this, the guanosine monophosphate (GMP) gene synthesis segment is estimated to account for a significant share.
Growing demand for advanced synthetic biology services to augment the growth of the Research and Development segment
As per FMI, the research and development segment is estimated to hold a significant market share, accounting for more than 35% of the gene synthesis demand by 2033.
Demand for cost-effective and advanced synthetic biology services for double-stranded DNA molecule synthesis is expected to surge the segment's share. Synthetic DNA and RNA genome sequencing, heterologous gene expression, and others are widely used in research and development. Massive investments by governments worldwide in various research projects are also expected to drive market growth.
The start-ups are developing technologies to scale up the production of gene manufacturing technology. For example, they employ a specifically engineered enzyme to enable robust and scalable DNA synthesis. That would allow the one-step generation of long, high-fidelity DNA fragments without limiting the maximum length.
Camena Bioscience: The United States-based start-up enables precise nucleic acid synthesis. The enzymatic de novo synthesis and gene assembly solution developed by the start-up produces long and complex DNA molecules with high accuracy. The technology goes by the name gSynth. It also allows synthetic biology companies to manufacture precise gene variant libraries for protein engineering.
The companies operating in the gene synthesis market are expanding their single-guide RNA manufacturing capabilities. This would certainly enable next-generation gene and cell therapy research and development programs to advance their clinical trials. In December 2022, cell and gene therapy companies leveraged GenScript’s cGMP and sgRNA capability to accelerate speed.
Key developments in the market are:
| Company | Description |
|---|---|
| Twist Bioscience | Twist Bioscience has been working in the service of customers who are changing the world for better. By using the DNA synthetic tools in medicine, agriculture, industrial chemicals, and data storage, the company is looking for ways to drive better lives and sustainability in the planet. The innovative method of DNA production adopted by the company allows in the manufacturing of high-quality synthetic DNA. Twist sets the bar in product quality, meaning the product constantly meets specifications. |
| GenScript | GenScript Biotech Corporation is the world’s leading technology and service provider of life science research and development, and manufacture. The company was founded in New Jersey in 2002, and listed on the Hong Kong Stock Exchange in 2015. GenScript’s business operations span over 100 countries and regions. The company has been providing premium, convenient, and reliable services and products to over 200,000 customers. Driven by the mission, ‘make people and nature healthier through biotechnology’, the company strives to become the most trustworthy biotech firm. |
| ProteoGenix | ProteoGenix was started in 2003 to develop diagnostic assays and biotherapeutics to target proteins discovered by its proteins. The company realized the incredible value of high-quality antibodies and proteins for developing biopharma products. As a service integrator, the ProteoGenix guides its customers from early discovery to the clinic. The main objective of the company is to anticipate future requirements of the biomolecules from the beginning and to subsequently design a sustainable development strategy. |
Other significant gene synthesis companies profiled: Brooks Automation, Inc., Boster Biological Technology
The gene synthesis service holds high revenue potential.
The United States, the United Kingdom, Japan and China are estimated to dominate the global market.
The market is forecast to register a CAGR of 19.2% through 2033.
During 2018 to 2022, the market registered a CAGR of 19.9%.
The growing innovations in product services are increasing current market trends.
1. Executive Summary | Gene Synthesis Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Service Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Service Type, 2017 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service Type, 2023 to 2033 5.3.1. Service 5.3.1.1. Standard Gene Service 5.3.1.2. Express Gene Service 5.3.1.3. Complex Gene Service 5.3.1.4. Custom Service 5.3.2. Gene Fragments Service 5.3.3. GMP Gene Synthesis 5.3.4. Others 5.4. Y-o-Y Growth Trend Analysis By Service Type, 2017 to 2022 5.5. Absolute $ Opportunity Analysis By Service Type, 2023 to 2033 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Diagnostics 6.3.2. Therapeutics 6.3.3. Reseach and Development Activities 6.3.4. Other Application 6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2017 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033 7.3.1. Academic and Research Institutes 7.3.2. Biotechnology Companies 7.3.3. Pharmaceutical Companies 7.3.4. Contract Research Organisation 7.4. Y-o-Y Growth Trend Analysis By End User , 2017 to 2022 7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia 8.3.6. Oceania 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Service Type 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Service Type 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Mexico 10.2.1.2. Brazil 10.2.1.3. Argentina 10.2.1.4. Rest of Latin America 10.2.2. By Service Type 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Service Type 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. United Kingdom 11.2.1.2. Germany 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Russia 11.2.1.7. BENELUX 11.2.1.8. Rest of Europe 11.2.2. By Service Type 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Service Type 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Service Type 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Service Type 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Thailand 13.2.1.2. Malaysia 13.2.1.3. India 13.2.1.4. Indonesia 13.2.1.5. Rest of South Asia 13.2.2. By Service Type 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Service Type 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Service Type 14.2.3. By Application 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Service Type 14.3.3. By Application 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Türkiye 15.2.1.4. Northern Africa 15.2.1.5. Rest of Middle East and Africa 15.2.2. By Service Type 15.2.3. By Application 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Service Type 15.3.3. By Application 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Service Type 16.1.2.2. By Application 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Service Type 16.2.2.2. By Application 16.2.2.3. By End User 16.3. Mexico 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Service Type 16.3.2.2. By Application 16.3.2.3. By End User 16.4. Brazil 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Service Type 16.4.2.2. By Application 16.4.2.3. By End User 16.5. Argentina 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Service Type 16.5.2.2. By Application 16.5.2.3. By End User 16.6. United Kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Service Type 16.6.2.2. By Application 16.6.2.3. By End User 16.7. Germany 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Service Type 16.7.2.2. By Application 16.7.2.3. By End User 16.8. France 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Service Type 16.8.2.2. By Application 16.8.2.3. By End User 16.9. Spain 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Service Type 16.9.2.2. By Application 16.9.2.3. By End User 16.10. Italy 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Service Type 16.10.2.2. By Application 16.10.2.3. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Service Type 16.11.2.2. By Application 16.11.2.3. By End User 16.12. BENELUX 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Service Type 16.12.2.2. By Application 16.12.2.3. By End User 16.13. China 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Service Type 16.13.2.2. By Application 16.13.2.3. By End User 16.14. Japan 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Service Type 16.14.2.2. By Application 16.14.2.3. By End User 16.15. South Korea 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Service Type 16.15.2.2. By Application 16.15.2.3. By End User 16.16. Thailand 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Service Type 16.16.2.2. By Application 16.16.2.3. By End User 16.17. Malaysia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Service Type 16.17.2.2. By Application 16.17.2.3. By End User 16.18. India 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Service Type 16.18.2.2. By Application 16.18.2.3. By End User 16.19. Indonesia 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Service Type 16.19.2.2. By Application 16.19.2.3. By End User 16.20. Australia 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Service Type 16.20.2.2. By Application 16.20.2.3. By End User 16.21. New Zealand 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Service Type 16.21.2.2. By Application 16.21.2.3. By End User 16.22. GCC Countries 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Service Type 16.22.2.2. By Application 16.22.2.3. By End User 16.23. South Africa 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Service Type 16.23.2.2. By Application 16.23.2.3. By End User 16.24. Türkiye 16.24.1. Pricing Analysis 16.24.2. Market Share Analysis, 2022 16.24.2.1. By Service Type 16.24.2.2. By Application 16.24.2.3. By End User 16.25. Northern Africa 16.25.1. Pricing Analysis 16.25.2. Market Share Analysis, 2022 16.25.2.1. By Service Type 16.25.2.2. By Application 16.25.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Service Type 17.3.3. By Application 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. GenScript 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Brooks Automation, Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Boster Biological Technology 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Twist Bioscience 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. ProteoGenix 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Biomatik 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Eurofins Scientific 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. ProMab Biotechnologies, Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Thermo Fisher Scientific, Inc. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Integrated DNA Technologies, Inc. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. OriGene Technologies, Inc. 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Gene Synthesis Market
